Literature DB >> 9697263

Micrometastatic colorectal cancer lesions in the liver.

M Nanko1, H Shimada, H Yamaoka, K Tanaka, H Masui, K Matsuo, H Ike, S Oki, M Hara.   

Abstract

A surgical resection of metastatic liver lesions from colorectal cancer contributes to an improved prognosis. However, the postoperative recurrence rate remains high, particularly in the residual liver. This is probably the result of the failure to detect small lesions. In the present study, we histologically examined the presence of intrahepatic micrometastases, which are considered to be related to recurrence in the residual liver. Intrahepatic micrometastases were histologically examined in 31 resected specimens of 25 patients undergoing a hepatic resection because of metastasis to the liver from colorectal cancer. Micrometastases were found in 14 of 25 cases (56.0%). They were located in the portal veins, central veins, sinusoid, and bile ducts. The longest distance from the main metastasis was 38.2 (mean 7.5 +/- 8.0) mm. The size of the macrometastases became larger, and the frequency of micrometastases and the distance of micrometastases from macrometastases had a tendency to increase. Continuous invasion of the macrometastases into the micrometastases through the vasculature or bile duct was also observed. These results suggested that some micrometastases observed in the metastatic liver from colorectal cancer were thus seeded from the primary lesions, while other micrometastases originated from the macrometastatic lesions as satellite lesions.

Entities:  

Mesh:

Year:  1998        PMID: 9697263     DOI: 10.1007/BF02484616

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  Elective hepatic resection for benign and malignant liver disease: early results.

Authors:  N A Habib; M K Koh; G Zografos; R W Awad; G Bottino
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

2.  Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study.

Authors:  B van Ooijen; T Wiggers; S Meijer; M N van der Heijde; M J Slooff; C J van de Velde; H Obertop; D J Gouma; E D Bruggink; J F Lange
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

3.  Pattern of recurrence after hepatic resection for colorectal metastases.

Authors:  K Sugihara; K Hojo; Y Moriya; S Yamasaki; T Kosuge; T Takayama
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

4.  Hepatic resection in 125 patients.

Authors:  T Tsuzuki; Y Ogata; S Iida; M Shimazu
Journal:  Arch Surg       Date:  1984-09

5.  The clinical correlation of an autopsy study of recurrent colorectal cancer.

Authors:  J P Welch; G A Donaldson
Journal:  Ann Surg       Date:  1979-04       Impact factor: 12.969

6.  [A histopathological investigation of metastatic liver tumors--the classification of their histological patterns and metastatic pathways taking into account the microscopic metastatic foci].

Authors:  H Shibata
Journal:  Gan No Rinsho       Date:  1989-02
  6 in total
  15 in total

Review 1.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 2.  Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2005-12-01       Impact factor: 3.445

Review 3.  Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis.

Authors:  Wei Liu; Yi Sun; Lei Zhang; Bao-Cai Xing
Journal:  Int J Colorectal Dis       Date:  2015-07-23       Impact factor: 2.571

4.  Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Hitoshi Kameyama; Hitoshi Nogami; Tsuneo Iiai; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  Int J Clin Exp Pathol       Date:  2012-04-16

5.  Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.

Authors:  Satoshi Okazaki; Hironobu Baba; Noriko Iwata; Shinichi Yamauchi; Kenichi Sugihara
Journal:  Surg Today       Date:  2017-04-24       Impact factor: 2.549

6.  Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Mitsuyoshi Ohta; Shinji Togo; Shuji Saitou; Shigeki Yamaguchi; Itaru Endo; Hitoshi Sekido
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

7.  Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases.

Authors:  Max Seidensticker; Peter Wust; Ricarda Rühl; Konrad Mohnike; Maciej Pech; Gero Wieners; Günther Gademann; Jens Ricke
Journal:  Radiat Oncol       Date:  2010-03-24       Impact factor: 3.481

8.  Rebound growth of hepatic colorectal metastases after neo-adjuvant chemotherapy: effect on survival after resection.

Authors:  Elizabeth Lim; Matthew G Wiggans; Golnaz Shahtahmassebi; Somaiah Aroori; Matthew J Bowles; Christopher D Briggs; David A Stell
Journal:  HPB (Oxford)       Date:  2016-05-20       Impact factor: 3.647

9.  Recurrence location after resection of colorectal liver metastases influences prognosis.

Authors:  K M Govaert; C S van Kessel; E J A Steller; B L Emmink; I Q Molenaar; O Kranenburg; R van Hillegersberg; I H M Borel Rinkes
Journal:  J Gastrointest Surg       Date:  2014-01-29       Impact factor: 3.452

Review 10.  Combination of ablation and embolization for intermediate-sized liver metastases from colorectal cancer: what can we learn from treating primary liver cancer?

Authors:  Matthew J Seager; Tobias F Jakobs; Ricky A Sharma; Steve Bandula
Journal:  Diagn Interv Radiol       Date:  2021-09       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.